Travere Therapeutics Investor Relations Material
Latest events
Q4 2023
Travere Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Travere Therapeutics Inc
Access all reports
Travere Therapeutics, Inc. is a biopharmaceutical company focused on the identification, development, and commercialization of therapies for the treatment of rare diseases. Travere Therapeutics Inc., are committed to meeting the needs of patients suffering from rare diseases by developing and providing treatments that have the potential to improve their lives. Incorporated in 2008 with a focus on bringing a pathway to approval for people living with these diseases without treatment options, our clinical portfolio includes several ongoing clinical studies in diseases for which there is no approved therapy.
Key slides for Travere Therapeutics Inc
Corporate Presentation
Travere Therapeutics Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Travere Therapeutics Inc
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States